Price, D., Fox, H., Surrey, K., & Reisner, C. (2006). ABS38: Add-on omalizumab significantly improves quality of life in patients with severe persistent allergic (IgE-mediated) asthma. Prim Care Respir J.
শিকাগো স্টাইলে সাইটেশনPrice, D., H. Fox, K. Surrey, এবং C. Reisner. "ABS38: Add-on Omalizumab Significantly Improves Quality of Life in Patients With Severe Persistent Allergic (IgE-mediated) Asthma." Prim Care Respir J 2006.
এমএলএ সাইটেশনPrice, D., H. Fox, K. Surrey, এবং C. Reisner. "ABS38: Add-on Omalizumab Significantly Improves Quality of Life in Patients With Severe Persistent Allergic (IgE-mediated) Asthma." Prim Care Respir J 2006.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.